Skip directly to site content Skip directly to search


Español  Other Languages


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
 Search
		×
			Vaccines site
			Vaccines site
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


Advisory Committee on Immunization Practices (ACIP)








ACIP Presentation Slides: October 25-26, 2023 Meeting						Print
																Related Pages
										Note: These files are not yet 508
Slides will be added as they become available.
October 25, 2023
Welcome & Introductions
IntroductionDr. G Lee
Dr. M WhartonMeningococcal Vaccines
Introduction [7 pages]Dr. K Poehling
Plan for revisiting adolescent schedule for meningococcal vaccines [7 pages]Dr. L McNamara
Comparison of Pfizer and CDC cost effectiveness analyses [25 pages]Dr. I Ortega-Sanchez
Summary of EtR and proposed recommendations for Pfizer’s MenABCWY vaccine [42 pages]Dr. J CollinsMpox Vaccines
Introduction [17 pages]Dr. P Sanchez
Updates about U.S. mpox epidemiology, vaccine safety, and vaccine effectiveness [40 pages]Dr. F Minhaj
Evidence to recommendations framework [45 pages]Dr. A Rao
Review of voting language and clinical guidance [15 pages]Dr. A RaoRSV – Adults
Introduction [8 pages]Dr. C Kotton
GSK safety and immunogenicity in persons 50-59 years of age [26 pages]Dr. S Gerber
Epidemiology of RSV in adults [39 pages]Dr. M Patton
Work group interpretation and ACIP discussion [26 pages]Dr. A BrittonInfluenza Vaccines
Introduction [7 pages]Dr. J Loehr
Safety of quadrivalent recombinant influenza vaccine in pregnant women and their infants [19 pages]Dr. N Klein
Pregnancy outcomes with ccIIV4 (Flucelvax): results of a post-marketing study [13 pages]Dr. G Sylvester
Safety of simultaneous versus sequential administration of mRNA COVID-19 and Quadrivalent Inactivated Influenza (IIV4) Vaccines: A randomized placebo controlled trial [37 pages]Dr. C Walter
Safety of simultaneous vaccination with Zoster Vaccine Recombinant (RZV) and quadrivalent Adjuvanted Inactivated Influenza Vaccine (allV4) [31 pages]Dr. K SchmaderVaccine Safety Update
Update on COVID-19 and Influenza Vaccine Safety [20 pages]Dr. T ShimabukuroOctober 26, 2023
Welcome & Introductions
IntroductionDr. G Lee
Dr. M WhartonCombined Immunization Schedules
Introduction to 2024 adult and child/adolescent immunization schedule [11 pages]Dr. S Cineas
2024 child and adolescent schedule revisions [61 pages]Dr. P Wodi
2024 adult schedule revisions [50 pages]Dr. N MurthyChikungunya Vaccine
Introduction [6 pages]Dr. B Bell
EtR and proposed policy options for chikungunya vaccine use among U.S. adults traveling abroad [67 pages]Dr. S Hills
EtR and proposed policy options for chikungunya vaccine use among laboratory workers [15 pages]Dr. S HillsDengue Vaccine
Takeda dengue vaccine update [11 pages]Dr. W ChenCOVID-19 Vaccines
Introduction [7 pages]Dr. M Daley
COVID-19 vaccine implementation [18 pages]Dr. S Stokley
COVID-19 vaccine policy and next steps [24 pages]Dr. M WallacePneumococcal Vaccines
Work Group Updates and Next Steps [13 pages]Dr. M KobayahsiInfluenza Vaccines
Effectiveness of maternal influenza vaccination during pregnancy against influenza-associated hospitalizations & emergency department visits in infants <6 Months of Age [27 pages]Ms. S Olson
Update on influenza B/Yamagata surveillance [15 pages]Dr. R Kondor
							
					
							Last Reviewed:  October 26, 2023						Source: 	National Center for Immunization and Respiratory Diseases
					Facebook
        Twitter
        LinkedIn
        Syndicate homeACIP Home
Meeting Information
Committee Informationplus icon
Role of the ACIP in CDC’s Vaccine Recommendations
Charter
Economics Studies
Committee Membersplus icon
ACIP Membership Roster
Apply for ACIP Membership
Work Groupsplus icon
VaST Reportsplus icon
June 28, 2021
May 24, 2021
May 17, 2021
March 29, 2021
Recommendationsplus icon
Shared Clinical Decision-Making Recommendations
Evidence Based Recommendationsplus icon
About GRADE
Grade Evidence Tables
Evidence to Recommendations Frameworks Vaccines & ImmunizationsImmunization SchedulesVFC ResolutionsVaccine Information Statements (VISs)
  1600 Clifton Road, N.E., Mailstop A27
Atlanta, GA 30329-4027acip@cdc.gov


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue